-
881
Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
Published 2013-01-01“…Pegfilgrastim (Neulasta) is a recombinant filgrastim (human granulocyte colony-stimulating factor (G-CSF)) attached to a polyethylene glycol (PEG) molecule and is given as part of chemotherapy regimens that are associated with significant myelosuppression and risk for febrile neutropenia. …”
Get full text
Article -
882
Angiosarcoma Arising in a Patient with a 10-Year-Old Hemangioma
Published 2014-01-01“…She declined systemic adjuvant chemotherapy after a thorough discussion about the risks and benefits of chemotherapy, and she currently remains disease free one year after the surgery.…”
Get full text
Article -
883
Obstructive shock secondary to an unusual cause: primary cardiac lymphoma
Published 2025-01-01“…Conclusion When a cardiac mass is associated with extracardiac symptoms indicative of a hematological malignancy, the preferred treatment is chemotherapy, and cardiac surgery should be avoided.…”
Get full text
Article -
884
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
Published 2016-01-01“…Research to date suggests use of monoclonal antibodies against different CD44 variant isoforms and targeted inhibition of HA/CD44-mediated signaling combined with conventional radio/chemotherapy may be the most favorable therapeutic strategy for future treatments of advanced stage malignancies. …”
Get full text
Article -
885
Endovascular Treatment of Vertebral Column Metastases Using Intra-Arterial Cisplatin: Pilot Experience
Published 2014-01-01“…Treatment of spinal column metastatic tumors is challenging, especially in the setting of progressive disease despite previous radiation and chemotherapy. Intra-arterial chemotherapy is an uncommonly used but established treatment for head and neck cancers, retinoblastoma, and glioblastoma. …”
Get full text
Article -
886
Bilateral Breast Masses with a Rare Etiology
Published 2013-01-01“…Six months after finishing chemotherapy the patient remained in complete remission. …”
Get full text
Article -
887
Acute Progressive Visual Loss in a Case of Acute Myeloid Leukemia: Challenges in the Utility of Molecular Tests in Early Diagnose of Cytomegalovirus Retinitis
Published 2018-01-01“…Viral infections, especially cytomegalovirus infection, may present with vague clinical pictures during any time of chemotherapy, which may not be easily distinguishable from bacterial or fungal retinitis and also chemotherapy-induced retinopathies. …”
Get full text
Article -
888
Perioperative Radiotherapy in the Management of Rectal Cancer
Published 2001-01-01“…However, when postoperative irradiation has been combined with chemotherapy, a survival benefit has been demonstrated. …”
Get full text
Article -
889
An Atypical Presentation of Sporadic Jejunal Burkitt’s Lymphoma
Published 2016-01-01“…Treatment consisted of bowel resection prior to chemotherapy due to concern for perforation with chemotherapy. …”
Get full text
Article -
890
Changing Management of Clinical Low-Stage Testicular Cancer
Published 2005-01-01“…The management of clinical stage I testicular GCTs has grown more complicated due to the emergence of a brief course of chemotherapy as an additional treatment option for stage I seminomas and stage I nonseminomas. …”
Get full text
Article -
891
Delayed Migration of a WallFlex Enteral Stent Resulting in Jejunal Perforation
Published 2013-01-01“…Four months later, while actively undergoing chemotherapy, he developed acute abdominal pain and was found to have delayed stent migration and jejunal perforation. …”
Get full text
Article -
892
Metastases to the Thyroid Presenting as a Metabolically Inactive Incidental Thyroid Nodule with Stable Size in 15 Months
Published 2014-01-01“…A 63-year-old male with history of adenocarcinoma of the right lobe lung (5 years prior to presentation), treated with surgery and chemotherapy, followed by new adenosquamous lung cancer in the left lobe of the lung (one year prior to presentation), treated surgically followed by adjuvant chemotherapy, was referred to Endocrinology section for evaluation of an incidental thyroid nodule on CT chest. …”
Get full text
Article -
893
Anti-Toxoplasma Effects of Dracocephalum Polychaetum Essential Oil
Published 2022-01-01“…Toxoplasma gondii is a common parasitic disease with a cosmopolitan prevalence, causing severe health problems. Although chemotherapy for toxoplasmosis is readily available, most have side effects. …”
Get full text
Article -
894
Growing Teratoma Syndrome
Published 2014-01-01“…Growing teratoma syndrome (GTS) is a rare clinical entity, which presents with enlarging teratomas masses of the retroperitoneum or other locations, occurring during or after systemic chemotherapy for the treatment of nonseminomatous germ cell of the testis (NSGCT), with normalised tumour markers. …”
Get full text
Article -
895
Comparison of Cantharidin Toxicity in Breast Cancer Cells to Two Common Chemotherapeutics
Published 2014-01-01“…As part of a larger study synthesizing a more directed form of chemotherapy, we have begun to assess the efficacy of different potential toxins that could be delivered locally rather than systemically. …”
Get full text
Article -
896
Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy
Published 2013-01-01“…At one-year followup, he had complete response to chemotherapy for ALL, with residual mild left hemiparesis, and his MRI scans revealed recanalized venous sinuses. …”
Get full text
Article -
897
Primary ovarian peripheral primitive neuroectodermal tumor presented with breast metastasis; Case report
Published 2025-01-01“…Despite treatment with radiotherapy and two cycles of high-dose Ifosfamide chemotherapy, her condition deteriorated, and she passed away in April 2024. …”
Get full text
Article -
898
Acute Cardiogenic Shock Induced by Infusional 5-Fluorouracil
Published 2014-01-01“…A follow-up echocardiogram performed 5 days after initial presentation revealed an ejection fraction of 59 percent, with no evidence of wall motion abnormalities. Subsequent 5-FU chemotherapy was discontinued, and the patient went on to receive second-line chemotherapy.…”
Get full text
Article -
899
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
Published 2025-01-01“…The addition of anti-PD-1 monoclonal antibodies to chemotherapy has been shown to extend progression-free survival in recurrent r/m NPC compared to chemotherapy alone; however, approval of PD-1 inhibitors in Canada has lagged behind other jurisdictions where NPC is non-endemic. …”
Get full text
Article -
900
Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database...
Published 2024-12-01“…Results Among 9206 patients with mNSCLC, 164 (1.78%) met the eligibility criteria (mean age: 67.3 years, 63.4% White, 56.7% female, and 53.0% with a smoking history). 132/164 (80.5%) had at least one line of treatment. Platinum‐based chemotherapy (45.5%) and immune checkpoint inhibitor (ICI) with chemotherapy (28.0%) were the most frequently used first‐line treatments. …”
Get full text
Article